Le Lézard
Classified in: Health, Science and technology
Subject: IPO

Karuna Therapeutics Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering


Karuna Therapeutics, Inc. today announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.


These press releases may also interest you

at 18:45
The "Proteomics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report describes and evaluates the proteomic technologies that will play an important role in drug...

at 18:30
RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased AAC Holdings, Inc. ("AAC" or the "Company") between March 8, 2017 and April 15, 2019, inclusive (the "Class Period")....

at 18:30
The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the...

at 18:10
Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced that an abstract describing clinical data regarding their lysine-specific demethylase (LSD1)...

at 18:08
This report provides forecast and analysis of the global medical nutrition market.It provides estimated data of 2018, and forecast data up to 2027 in terms of revenue (US$ Mn) and volume (metric tons).Read the full report:...

at 18:08
About this marketThe increasing number of cervical cancer endoscopic device launches is one of the key factors that will trigger the market growth during the forecast period. With the rising prevalence of cervical cancer, manufacturers are focusing...



News published on 26 april 2019 at 02:05 and distributed by: